Trade YDES stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
YD Bio Limited (YDES) is trading at US$4.00, up 2.56% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$332.2M. Over the past 52 weeks, YDES has traded between US$1.70 and US$23.00. On Syfe you can trade YDES with $0 commission and add it to your watchlist.
| Previous close | US$3.90 |
|---|---|
| Market cap | US$332.2M |
| 52-week range | US$1.70 – US$23.00 |
| Volume | 819.27K |
| Exchange | US |
Add to Watchlist
Set Price Alert
YD Bio Limited
YD Bio Ltd. is a biotechnology company building an integrated healthcare platform across regulated diagnostics, clinical services, and commercial healthcare markets. It operates DNA methylation–based oncology testing programs under an LDT-first strategy and provides compliant life science distribution and clinical trial supply chain services to pharmaceutical and biotechnology partners. The company’s offerings include cancer detection products, regenerative ophthalmology solutions, and exosome-based technologies. YD Bio was founded on February 6, 2024 and is headquartered in Taipei, Taiwan.
Year: 2025
YD Bio Launches EG Telehealth Platform in Partnership With EG BioMed
Mar 31, 1:14 PM · MT Newswires
YD Bio Limited (YDES) stock is trading at US$4.00, +2.56% from the previous close of US$3.90.
The market cap for YD Bio Limited (YDES) stock is approximately US$332.2M.
The 52-week high for YD Bio Limited (YDES) stock is US$23.00.
The 52-week low for YD Bio Limited (YDES) stock is US$1.70.
YD Bio Limited (YDES) does not currently pay a dividend.
Stay on top of YDES
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
